Urogenital side effects in male subjects with type 2 diabetes treated with SGLT-2 inhibitors: A single centre, longitudinal observation

SGLT-2 inhibitors (SGLT-2i) provide good glycaemic control and weight loss, ensuring clinically relevant cardiorenal benefits in subjects with and without type 2 diabetes (T2D); however, their use is related to an enhanced risk of urogenital infections, mainly in female subjects. We performed a pros...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of diabetes and its complications Ročník 39; číslo 5; s. 109015
Hlavní autori:	Del Zoppo, Alice, Rovera, Chiara, Petralli, Giovanni, Moriconi, Diego, Solini, Anna
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 01.05.2025 Elsevier Limited
Predmet:	Aged Biochemistry BMI Clinical trials Compliance Creatinine Diabetes Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology DPP-IV inhibitors Fasting Females Genotype & phenotype Glucose Heart failure Hospitals Humans Incidence Infections Laboratories Longitudinal Studies Male Male Urogenital Diseases - chemically induced Male Urogenital Diseases - epidemiology Metabolism Middle Aged Prospective Studies SGLT-2 inhibitors Side effects Sodium-Glucose Transporter 2 Inhibitors - adverse effects Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Urogenital complications DPP-IV inhibitors SGLT-2 inhibitors Compliance Urogenital complications BMI
ISSN:	1056-8727, 1873-460X, 1873-460X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!